Infection prevention specialist Tristel (TSTL) is working with Byotrol (BYOT) – a micro-cap provider of antimicrobial technologies – to develop a new surface disinfectant product for hospitals.
IC TIP:
Buy
at
459p
The groups have entered into a ‘know-how’ licence and commercial collaboration to develop a longer-lasting version of Tristel's high-end surface disinfectant. Byotrol's technology can make surface disinfectants effective for up to eight hours. This compares with a current 'kill time' of 30-60 seconds. The new formulations that will be supplied and licensed to Tristel will be branded Tristel8.
